Evidence map›Paper›PMID 39518007›Full record

ArticleCancers2024

The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer-CEEGOG OX-01 Study.

Jiri Presl, Pavel Havelka, Vit Weinberger, Petra Ovesna, Peter Fekete, Filip Fruhauf, Marcin Jedryka, Branislav Bystricky, Aleksandra Strojna, Nataliya Volodko and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Jiri PreslDepartment of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic.ORCID 0000-0001-7632-4069
Pavel HavelkaDepartment of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic.
Vit WeinbergerDepartment of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0003-4858-1951
Petra OvesnaInstitute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0002-3547-5896
Peter FeketeDepartment of Gynecological Oncology, St. Elizabeth Cancer Institute, 811 08 Bratislava, Slovakia.
Filip FruhaufDepartment of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
Marcin JedrykaGynecological Oncology Department, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw Medical University, 53-413 Wroclaw, Poland.ORCID 0000-0001-8935-0311
Branislav BystrickyDepartment of Oncology, Faculty Hospital Trencin, Faculty of Healthcare, Alexander Dubcek University of Trencin, 911 06 Trencin, Slovakia.ORCID 0000-0002-9622-8557
Aleksandra StrojnaDepartment of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland.ORCID 0000-0002-8749-4642
Nataliya VolodkoDepartment of Oncology and Radiology, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine.
Olga MatylevichGynecologic Oncology Division, NN Alexandrov National Cancer Centre, 223040 Minsk, Belarus.
Petra HerboltovaDepartment of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, Charles University, 306 05 Pilsen, Czech Republic.
Pawel BlecharzDepartment of Gynecologic Oncology, National Cancer Institute, M. Sklodowska-Curie Memorial Institute, 31-115 Cracow, Poland.
Vladimir KalistDepartment of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic.
Lucie EhrlichovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic.
Petr StranikDepartment of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Ladislav MasakDepartment of Gynecological Oncology, St. Elizabeth Cancer Institute, 811 08 Bratislava, Slovakia.
Renata PoncovaDepartment of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
Andrzej CzekanskiGynecological Oncology Department, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw Medical University, 53-413 Wroclaw, Poland.ORCID 0000-0002-7598-5401
Barbora ChaloupkovaDepartment of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic.
Michaela KoblizkovaDepartment of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic.
Vendula SmoligovaDepartment of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Marketa HrabalovaDepartment of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic.
Alena JaksicovaDepartment of Oncology, KNTB a.s Zlin, 762 75 Zlin, Czech Republic.
Peter LinkeschDepartment of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic.
Libor ViktoraDepartment of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic.
Jiri BoudaDepartment of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Pavel VlasakDepartment of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Jan KostunDepartment of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CA125HE4ovarian cancerrecurrence detectiontumor markers

Identifiers

PMID39518007
PMCPMC11544767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.